This is a standard, routine filing. Traders should note the board's unanimous recommendation for all management proposals and the opposition to the shareholder proposals. The lack of any contested director elections or significant governance issues suggests stability in the company's leadership, which may be viewed as a neutral factor for long-term investors.
Price Chart
Executive Summary
HCA Healthcare has filed its definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, scheduled for April 23, 2026. The filing outlines the board's recommendations for shareholder votes on the election of nine director nominees, the ratification of Ernst & Young as the independent auditor, an advisory vote on executive compensation, and opposition to two shareholder proposals regarding a healthcare consequences report and shareholder rights to act by written consent.
Key Facts
- The filing is a definitive proxy statement (DEFA14A) for HCA Healthcare's 2026 Annual Meeting.
- The meeting is scheduled for April 23, 2026, and voting must be completed by April 22, 2026.
- The board recommends voting 'For' the election of all nine director nominees: Thomas F. Frist III, Samuel N. Hazen, John W. Chidsey, III, Nancy-Ann DeParle, William R. Frist, Hugh F. Johnston, Michael W. Michelson, Wayne J. Riley, M.D., and Andrea B. Smith.
- The board recommends voting 'For' the ratification of Ernst & Young LLP as the independent auditor.
- The board recommends voting 'For' the advisory vote to approve named executive officer compensation.
- The board recommends voting 'Against' two shareholder proposals: one on a report on healthcare consequences and another on shareholder rights to act by written consent.
Financial Impact
None. This is a routine procedural filing with no direct financial impact.
Risk Factors
- None identified. This is a routine, non-material filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-106153 |
| Document: 0001193125-26-106153-index-headers.html | 0001193125-26-106153 |
| Document: 0001193125-26-106153-index.html | 0001193125-26-106153 |
| Document: 0001193125-26-106153.txt | 0001193125-26-106153 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 24, 2026 10w ago | 8-K | $382.19 $429.19 | ▲ +12.30% | ▲ +8.67% | $426.69 (+11.64%) |
Jul 14, 2026 11w ago | 8-K | $363.60 $411.44 | ▼ −13.16% | ▼ −10.67% | $426.69 (−17.35%) |
Jun 18, 2026 15w ago | 8-K | $375.17 $385.74 | ▲ +2.82% | ▲ +2.28% | $426.69 (+13.73%) |
Apr 27, 2026 22w ago | 8-K | $431.48 $392.42 | ▼ −9.05% | ▼ −14.52% | $426.69 (−1.11%) |
Apr 27, 2026 22w ago | Court Ruling | $445.70 $392.48 | ▼ −11.94% | ▼ −16.87% | $426.69 (−4.26%) |
Apr 24, 2026 23w ago | 8-K | $432.55 $392.56 | ▼ −9.25% | ▼ −13.27% | $426.69 (−1.36%) |
Mar 13, 2026 29w ago | DEFA14A | $525.04 $496.74 | ▼ −5.39% | ▼ −9.17% | $426.69 (−18.73%) |
Feb 25, 2026 31w ago | 8-K | $525.78 $479.78 | ▼ −8.75% | ▼ −2.35% | $426.69 (−18.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access